NEW YORK (GenomeWeb News) – Varian has provided Agilent Technologies with a written notice that it has extended the "end date" for their merger agreement 90 days to April 26, 2010.

Varian disclosed the extension in a US Securities and Exchange Commission filing last week. It said that the deal is still subject to regulatory approvals and other closing conditions.

Agilent signed a definitive agreement to acquire Varian for $52 per share, or a total of around $1.5 billion, back in July.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.